Publication | Closed Access

Comparison of Paclitaxel-Eluting Stents (Taxus) and Everolimus-Eluting Stents (Xience) in Left Main Coronary Artery Disease With 3 Years Follow-Up (from the ESTROFA-LM Registry)

Percutaneous Coronary InterventionCardiovascular DiseaseEstrofa-lm RegistryPaclitaxel-eluting StentsSurgeryEndovascular ManagementMedicineEverolimus-eluting StentsCoronary Artery Disease